Cutler Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605K Buy
1,671
+899
+116% +$308K 0.06% 103
2026
Q1
$272K Buy
772
+98
+15% +$34.9K 0.03% 133
2025
Q4
$221K Buy
+674
New +$214K 0.02% 140

Other funds holding AMGN

Cutler Investment Counsel's AMGN Position: Q2 2026 in Review

Cutler Investment Counsel increased its Amgen (AMGN) stake by 116% in Q2 2026, buying an estimated $308K and bringing the position to 1,671 shares worth $605K. The position accounts for 0.06% of the portfolio, ranked #103.

Cutler Investment Counsel first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cutler Investment Counsel held 1,671 shares of Amgen worth $605K as of Q2 2026.
  • Cutler Investment Counsel bought 899 Amgen shares in Q2 2026, an estimated $308K.
  • Amgen made up 0.06% of Cutler Investment Counsel's portfolio in Q2 2026, its #103 holding.
  • Cutler Investment Counsel first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cutler Investment Counsel's 13F filing for Q2 2026, filed 14 Jul 2026.